Network Analysis of Comorbid Anxiety and Insomnia Among Clinicians with Depressive Symptoms During the Late Stage of the COVID-19 Pandemic: A Cross-Sectional Study

Overview

Journal Nat Sci Sleep

Publisher Dove Medical Press

Date 2022 Aug 12

PMID 35959360

Authors

Hong Cai

Yan-Jie Zhao

Xiaomeng Xing

Tengfei Tian

Wang Qian

Sixiang Liang

Zhe Wang

Teris Cheung

Zhaohui Su

Yi-Lang Tang

Chee H Ng

Sha Sha

Yu-Tao Xiang

Affiliations

Soon will be listed here.

Abstract

Background: A high proportion of clinicians experienced common anxiety, insomnia and depression during the COVID-19 pandemic. This study examined the item-level association of comorbid anxiety and insomnia symptoms among clinicians who suffered from depressive symptoms during the late stage of the COVID-19 pandemic using network analysis (NA).

Methods: Clinicians with depressive symptoms (with a Patients Health Questionnaire (PHQ-9) total score of 5 and above) were included in this study. Anxiety and insomnia symptoms were measured using the Generalized Anxiety Disorder Scale - 7-item (GAD-7) and Insomnia Severity Index (ISI), respectively. Network analysis was conducted to investigate the network structure, central symptoms, bridge symptoms, and network stability of these disturbances. Expected influence (EI) was used to measure the centrality of index.

Results: Altogether, 1729 clinicians were included in this study. The mean age was 37.1 [standard deviation (SD)=8.04 years], while the mean PHQ-9 total score was 8.42 (SD=3.33), mean GAD-7 total score was 6.45 (SD=3.13) and mean ISI total score was 8.23 (SD=5.26). Of these clinicians, the prevalence of comorbid anxiety symptoms (GAD-7≥5) was 76.8% (95% CI 74.82-78.80%), while the prevalence of comorbid insomnia symptoms (ISI≥8) was 43.8% (95% CI: 41.50-46.18%). NA revealed that nodes ISI7 ("Interference with daytime functioning") (EI=1.18), ISI4 ("Sleep dissatisfaction") (EI=1.08) and ISI5 ("Noticeability of sleep problem by others") (EI=1.07) were the most central (influential) symptoms in the network model of comorbid anxiety and insomnia symptoms in clinicians. Bridge symptoms included nodes PHQ3 ("Sleep") (bridge EI=0.55) and PHQ4 ("Fatigue") (bridge EI=0.49). Gender did not significantly influence the network structure, but "having the experience of caring for COVID-19 patients" significantly influenced the network structure.

Conclusion: Central symptoms and key bridge symptoms identified in this NA should be targeted in the treatment and preventive measures for clinicians suffering from comorbid anxiety, insomnia and depressive symptoms during the late stage of the COVID-19 pandemic.

Citing Articles

Network of depression and anxiety symptoms in Chinese middle-aged and older people and its relationship with family health.

Ma S, Huang D, Ji S, Mi G, Zheng D Rev Esc Enferm USP. 2025; 58:e20240136.

PMID: 39918344 PMC: 11804662. DOI: 10.1590/1980-220X-REEUSP-2024-0136en.

Echoes of Strain: A Two-Year Longitudinal Study on the Impact of China's Zero-COVID Policy on College Students' Insomnia and Depressive Symptoms.

Wang S, Zou X, Tang Q, Zhang L, Liu X, Liu G Nat Sci Sleep. 2025; 17():81-96.

PMID: 39831053 PMC: 11740592. DOI: 10.2147/NSS.S490731.

Psychosomatic health status and corresponding comorbid network analysis of college students in traditional Chinese medicine schools.

Yi S, Hu X, Wang C, Ge J, Ma Z, Zhao Y Front Psychiatry. 2024; 15:1467064.

PMID: 39371914 PMC: 11450477. DOI: 10.3389/fpsyt.2024.1467064.

Machine learning and Bayesian network analyses identifies associations with insomnia in a national sample of 31,285 treatment-seeking college students.

Calderon A, Baik S, Ng M, Fitzsimmons-Craft E, Eisenberg D, Wilfley D BMC Psychiatry. 2024; 24(1):656.

PMID: 39367432 PMC: 11452987. DOI: 10.1186/s12888-024-06074-7.

Exploring the interconnections of anxiety, depression, sleep problems and health-promoting lifestyles among Chinese university students: a comprehensive network approach.

Sun C, Zhu Z, Zhang P, Wang L, Zhang Q, Guo Y Front Psychiatry. 2024; 15:1402680.

PMID: 39077626 PMC: 11284064. DOI: 10.3389/fpsyt.2024.1402680.

References

van Borkulo C, van Bork R, Boschloo L, Kossakowski J, Tio P, Schoevers R . Comparing network structures on three aspects: A permutation test. Psychol Methods. 2022; 28(6):1273-1285. DOI: 10.1037/met0000476. View

Chen W, Chen S, Zhong B . Sense of Alienation and Its Associations With Depressive Symptoms and Poor Sleep Quality in Older Adults Who Experienced the Lockdown in Wuhan, China, During the COVID-19 Pandemic. J Geriatr Psychiatry Neurol. 2022; 35(2):215-222. PMC: 8899829. DOI: 10.1177/08919887221078564. View

Ferguson M, Dennehy E, Marangell L, Martinez J, Wisniewski S . Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D. Curr Med Res Opin. 2014; 30(10):2109-18. DOI: 10.1185/03007995.2014.936553. View

Cai Q, Feng H, Huang J, Wang M, Wang Q, Lu X . The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control study. J Affect Disord. 2020; 275:210-215. PMC: 7329671. DOI: 10.1016/j.jad.2020.06.031. View

Ren L, Wang Y, Wu L, Wei Z, Cui L, Wei X . Network structure of depression and anxiety symptoms in Chinese female nursing students. BMC Psychiatry. 2021; 21(1):279. PMC: 8168020. DOI: 10.1186/s12888-021-03276-1. View

Rawtaer I, Mahendran R, Chan H, Lei F, Kua E . A nonpharmacological approach to improve sleep quality in older adults. Asia Pac Psychiatry. 2017; 10(2):e12301. DOI: 10.1111/appy.12301. View

Kroenke K, Spitzer R, Williams J, Lowe B . The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010; 32(4):345-59. DOI: 10.1016/j.genhosppsych.2010.03.006. View

Robinaugh D, Millner A, McNally R . Identifying highly influential nodes in the complicated grief network. J Abnorm Psychol. 2016; 125(6):747-57. PMC: 5060093. DOI: 10.1037/abn0000181. View

Al Maqbali M, Al Sinani M, Al-Lenjawi B . Prevalence of stress, depression, anxiety and sleep disturbance among nurses during the COVID-19 pandemic: A systematic review and meta-analysis. J Psychosom Res. 2020; 141:110343. PMC: 7831768. DOI: 10.1016/j.jpsychores.2020.110343. View

10.

Zavlis O, Butter S, Bennett K, Hartman T, Hyland P, Mason L . How does the COVID-19 pandemic impact on population mental health? A network analysis of COVID influences on depression, anxiety and traumatic stress in the UK population. Psychol Med. 2021; :1-9. PMC: 8010290. DOI: 10.1017/S0033291721000635. View

11.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

12.

Stahl S, Zhang L, Damatarca C, Grady M . Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J Clin Psychiatry. 2003; 64 Suppl 14:6-17. View

13.

Baldwin D, Papakostas G . Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry. 2006; 67 Suppl 6:9-15. View

14.

Folkman S, Greer S . Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other. Psychooncology. 2000; 9(1):11-9. DOI: 10.1002/(sici)1099-1611(200001/02)9:1<11::aid-pon424>3.0.co;2-z. View

15.

Altena E, Vrenken H, van der Werf Y, van den Heuvel O, van Someren E . Reduced orbitofrontal and parietal gray matter in chronic insomnia: a voxel-based morphometric study. Biol Psychiatry. 2009; 67(2):182-5. DOI: 10.1016/j.biopsych.2009.08.003. View

16.

Cheung Y, Yeo K, Chong K, Khoo E, Wee H . Measurement equivalence of the English, Chinese and Malay versions of the World Health Organization quality of life (WHOQOL-BREF) questionnaires. Health Qual Life Outcomes. 2019; 17(1):67. PMC: 6469132. DOI: 10.1186/s12955-019-1130-0. View

17.

Price M, Legrand A, Brier Z, Hebert-Dufresne L . The symptoms at the center: Examining the comorbidity of posttraumatic stress disorder, generalized anxiety disorder, and depression with network analysis. J Psychiatr Res. 2018; 109:52-58. PMC: 6420212. DOI: 10.1016/j.jpsychires.2018.11.016. View

18.

Spoormaker V, van den Bout J . Depression and anxiety complaints; relations with sleep disturbances. Eur Psychiatry. 2005; 20(3):243-5. DOI: 10.1016/j.eurpsy.2004.11.006. View

19.

Jahrami H, BaHammam A, Bragazzi N, Saif Z, Faris M, Vitiello M . Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med. 2020; 17(2):299-313. PMC: 7853219. DOI: 10.5664/jcsm.8930. View

20.

Barthel A, Pinaire M, Curtiss J, Baker A, Brown M, Hoeppner S . Anhedonia is central for the association between quality of life, metacognition, sleep, and affective symptoms in generalized anxiety disorder: A complex network analysis. J Affect Disord. 2020; 277:1013-1021. PMC: 7575821. DOI: 10.1016/j.jad.2020.08.077. View